PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 188 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,342,000 | +1.0% | 140,000 | -15.2% | 1.03% | -51.4% |
| Q3 2019 | $6,282,000 | +11.2% | 165,000 | +27.0% | 2.11% | +230.0% |
| Q2 2019 | $5,649,000 | -7.2% | 129,900 | -18.8% | 0.64% | -40.6% |
| Q1 2019 | $6,086,000 | -6.7% | 159,900 | +5.5% | 1.08% | +49.4% |
| Q4 2018 | $6,522,000 | -45.4% | 151,600 | -37.6% | 0.72% | -21.6% |
| Q3 2018 | $11,949,000 | +10.3% | 243,100 | -28.1% | 0.92% | +45.6% |
| Q2 2018 | $10,836,000 | -8.6% | 338,100 | -11.2% | 0.63% | -52.2% |
| Q1 2018 | $11,856,000 | -30.9% | 380,600 | +1.2% | 1.32% | -42.0% |
| Q4 2017 | $17,169,000 | -17.8% | 376,100 | -32.4% | 2.28% | -4.5% |
| Q3 2017 | $20,882,000 | +819.5% | 556,100 | +1068.3% | 2.39% | +323.8% |
| Q2 2017 | $2,271,000 | – | 47,600 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |